Fig. 2From: Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinibRelationship between triglyceride, total cholesterol, low density lipoprotein, and high density lipoprotein with progression-free survival rates (PA = 0.004, PB = 0.000, PC = 0.000, PD = 0.619)Back to article page